Open access
Open access
Powered by Google Translator Translator

Hematology

Clinical Guidance: Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic

25 May, 2020 | 01:43h | UTC

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum – Journal of Thrombosis and Thrombolysis

Related: Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet AND COVID-19 and its implications for thrombosis and anticoagulation – Blood AND Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis AND Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology

 


Coagulation Abnormalities and Thrombosis in Patients with COVID-19

12 May, 2020 | 03:16h | UTC

Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet

 

Related Commentary on Twitter

 


NCCN Guideline: Hematopoietic Cell Transplantation

10 May, 2020 | 23:53h | UTC

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


Meta-Analysis: Effects of Restrictive vs. Liberal Transfusion Strategies on Longer-term Outcomes After Cardiac Surgery

5 May, 2020 | 03:54h | UTC

The effect of restrictive versus liberal transfusion strategies on longer-term outcomes after cardiac surgery: a systematic review and meta-analysis with trial sequential analysis – Canadian Journal of Anesthesia

Related: Randomized Trial: In Patients Undergoing Cardiac Surgery, A Restrictive Transfusion Approach Does Not Increase the Risk of Acute Kidney Injury (selection of studies on the subject)

 


COVID-19 and Its Implications for Thrombosis and Anticoagulation

30 Apr, 2020 | 04:13h | UTC

COVID-19 and its implications for thrombosis and anticoagulation – Blood

 


Report: Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19

28 Apr, 2020 | 04:45h | UTC

Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands – Radiology

 


Position Statement on the Evaluation and Management of Patients with Cardiac Amyloidosis

13 Mar, 2020 | 07:59h | UTC

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis – Canadian Journal of Cardiology (free for a limited period)

 


Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with BCL-2 Inhibitors: Risk Factors, Prophylaxis, and Treatment Recommendations

18 Feb, 2020 | 08:04h | UTC

Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations – The Lancet Haematology (free registration required)

 


Immunization Strategies to Span the Spectrum of Immunocompromised Adults

16 Feb, 2020 | 20:43h | UTC

Immunization Strategies to Span the Spectrum of Immunocompromised Adults – Mayo Clinic Proceedings (free)

 


Review: How I Treat Cancer-associated Thrombosis

9 Feb, 2020 | 20:18h | UTC

How I treat cancer-associated thrombosis – ESMO Open (free)

Related: ASCO Guideline: Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer (free)

 


European Consensus Recommendation: Prophylaxis and Management of GVHD after Stem-cell Transplantation for Hematological Malignancies

2 Feb, 2020 | 19:51h | UTC

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation – The Lancet Haematology (free registration required)

 


A Network Meta-analysis of Maintenance Therapy in Chronic Lymphocytic Leukemia

31 Jan, 2020 | 00:54h | UTC

A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia – PLOS One (free)

 


BSH Guideline: Laboratory Diagnosis of G6PD Deficiency

30 Jan, 2020 | 07:36h | UTC

Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline – British Journal of Haematology (free)

 


Sickle Cell Disease: A Primary Care Update

30 Jan, 2020 | 07:32h | UTC

Sickle cell disease: A primary care update – Cleveland Clinic Journal of Medicine (free)

 


ASH Guidelines for Sickle Cell Disease: Transfusion Support

29 Jan, 2020 | 08:27h | UTC

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support – Blood Advances (free)

 


Recommendations for Therapeutic Apheresis

21 Jan, 2020 | 01:10h | UTC

Recommendations for Therapeutic Apheresis by the Section “Preparative and Therapeutic Hemapheresis” of the German Society for Transfusion Medicine and Immunohematology – Transfusion Medicine and Hemotherapy (free)

 


Addendum to BSH Guidelines on Investigation and Management of Antiphospholipid Syndrome: Use of Direct Acting Oral Anticoagulants

19 Jan, 2020 | 20:55h | UTC

Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47–58): use of direct acting oral anticoagulants – British Journal of Haematology (free)

Related: Randomized Trial: DOAC Not as Good as Vitamin K Antagonist for Anticoagulation in Antiphospholipid Syndrome (link to abstract and commentaries)

 


Review: Perioperative Antithrombotic (Antiplatelet and Anticoagulant) Therapy in Urological Practice

17 Jan, 2020 | 02:19h | UTC

Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines – World Journal of Urology (free)

 


Review: Surveillance in Patients with Diffuse Large B Cell Lymphoma

15 Jan, 2020 | 01:07h | UTC

Surveillance in Patients with Diffuse Large B Cell Lymphoma – Mayo Clinic Proceedings (free)

 


Meta-Analysis: Multiple Drug Combinations of Bortezomib, Lenalidomide, and Thalidomide for First‐line Treatment in Adults with Transplant‐Ineligible Multiple Myeloma

15 Jan, 2020 | 00:54h | UTC

Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis – Cochrane Library (free)

Summary: Multiple drug combinations of bortezomib, lenalidomide and thalidomide for initial treatment of adults with transplant-ineligible multiple myeloma – Cochrane Library (free)

Commentary: Featured Review: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma – Cochrane Library (free)

 


ESMO Guideline: Marginal Zone Lymphomas

14 Jan, 2020 | 00:26h | UTC

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up – Annals of Oncology (free)

 


Guideline: Transfusion Strategies in Non-bleeding Critically Ill Adults

8 Jan, 2020 | 08:50h | UTC

Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine – Intensive Care Medicine (free)

Editorial: Transfusion thresholds: the dangers of guidelines based on randomized controlled trials (free)

 


Consensus: Diagnosis and Treatment of Autoimmune Hemolytic Anemia in Adults

7 Jan, 2020 | 01:41h | UTC

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting – Blood Reviews (free)

Related: Autoimmune hemolytic anemia – Hematology (free) AND Guidelines on the management of drug‐induced immune and secondary autoimmune, haemolytic anaemia – British Journal of Haematology (free)

 


Position Statement: Diagnosis, Grading, and Treatment Recommendations for Children, Adolescents, and Young Adults with Sinusoidal Obstructive Syndrome

6 Jan, 2020 | 23:03h | UTC

Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement – The Lancet Haematology (free registration required)

Commentary: MD Anderson-convened consortium provides first universal recommendations for pediatric patients with sinusoidal obstructive syndrome (free)

 


Choosing Wisely in Pediatric Hematology: Five Things Physicians and Patients Should Question

11 Dec, 2019 | 08:16h | UTC

American Society of Hematology-American Society of Pediatric Hematology/Oncology: Five Things Physicians and Patients Should Question – Choosing Wisely (free)

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

Source: NEJM Journal Watch